Literature DB >> 7821144

Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study.

A Veves1, M J Young, C Manes, A J Boulton.   

Abstract

OBJECTIVE: To examine the differences in peripheral and autonomic nerve function measurements between diabetic patients without neuropathy (group 1, n = 38, mean age 50.9, range 29-71 years), with painless neuropathy (group 2, n = 32, mean age 49.2, range 30-71 years), and with painful neuropathy (group 3, n = 52, mean age 51.5, range 28-73 years). RESEARCH DESIGN AND METHODS: The evaluation of neuropathy was based on clinical symptoms, signs, and quantitative sensory testing, including current perception threshold (CPT) with a neurometer and electrophysiology.
RESULTS: The Neuropathy Symptom Score and the Neuropathy Disability Score were higher in patients with painful neuropathy compared with patients with painless neuropathy (6.8 +/- 2.7 vs. 0.5 +/- 0.8 [mean +/- SD], P < 0.0001, and 12.5 +/- 6.2 vs. 8.6 +/- 6.8, P < 0.01, respectively). In contrast, no differences were found in the quantitative sensory testing, including CPT measurements, the electrophysiological measurements, and the autonomic nerve system function tests in the two groups. Significant differences were found in all the above measurements when groups 2 and 3 were compared with diabetic patients without neuropathy (group 1). When all diabetic patients were considered as one group, significant correlations were found between CPT and the other peripheral nerve function assessments. In particular, peroneal nerve motor conduction velocity correlated with CPT at 2 kHz (r = -0.48, P < 0.001) and vibration perception threshold (r = -0.50, P < 0.001).
CONCLUSIONS: We conclude that no difference could be found in the function of small and large nerve fibers between painful and painless diabetic neuropathy using conventional tests currently used. The CPT evaluation failed to quantify painful symptoms, but it compared favorably with other quantitative sensory tests in quantifying peripheral neuropathy.

Entities:  

Mesh:

Year:  1994        PMID: 7821144     DOI: 10.2337/diacare.17.10.1200

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  14 in total

1.  Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction.

Authors:  A Caselli; V Spallone; G A Marfia; C Battista; C Pachatz; A Veves; L Uccioli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-19       Impact factor: 10.154

Review 2.  Advances in diabetes for the millennium: new treatments for diabetic neuropathies.

Authors:  Aaron I Vinik
Journal:  MedGenMed       Date:  2004-08-17

3.  Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy.

Authors:  Rajiv A Gandhi; Jefferson L B Marques; Dinesh Selvarajah; Celia J Emery; Solomon Tesfaye
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

4.  Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy.

Authors:  John Doupis; Thomas E Lyons; Szuhuei Wu; Charalambos Gnardellis; Thanh Dinh; Aristidis Veves
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

Review 5.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

6.  Quick discrimination of A(delta) and C fiber mediated pain based on three verbal descriptors.

Authors:  Florian Beissner; Amadeus Brandau; Christian Henke; Lisa Felden; Ulf Baumgärtner; Rolf-Detlef Treede; Bruno G Oertel; Jörn Lötsch
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

7.  Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.

Authors:  Tatsuhito Himeno; Hideki Kamiya; Keiko Naruse; Norio Harada; Nobuaki Ozaki; Yusuke Seino; Taiga Shibata; Masaki Kondo; Jiro Kato; Tetsuji Okawa; Ayako Fukami; Yoji Hamada; Nobuya Inagaki; Yutaka Seino; Daniel J Drucker; Yutaka Oiso; Jiro Nakamura
Journal:  Diabetes       Date:  2011-08-01       Impact factor: 9.461

8.  Angioblast Derived from ES Cells Construct Blood Vessels and Ameliorate Diabetic Polyneuropathy in Mice.

Authors:  Tatsuhito Himeno; Hideki Kamiya; Keiko Naruse; Zhao Cheng; Sachiko Ito; Taiga Shibata; Masaki Kondo; Jiro Kato; Tetsuji Okawa; Atsushi Fujiya; Hirohiko Suzuki; Tetsutaro Kito; Yoji Hamada; Yutaka Oiso; Kenichi Isobe; Jiro Nakamura
Journal:  J Diabetes Res       Date:  2015-04-21       Impact factor: 4.011

9.  Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice.

Authors:  Tetsuji Okawa; Hideki Kamiya; Tatsuhito Himeno; Yusuke Seino; Shin Tsunekawa; Yoshitaka Hayashi; Norio Harada; Yuichiro Yamada; Nobuya Inagaki; Yutaka Seino; Yutaka Oiso; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2013-10-16       Impact factor: 4.232

10.  Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats.

Authors:  Taiga Shibata; Keiko Naruse; Hideki Kamiya; Mika Kozakae; Masaki Kondo; Yutaka Yasuda; Nobuhisa Nakamura; Kimiko Ota; Takahiro Tosaki; Takashi Matsuki; Eitaro Nakashima; Yoji Hamada; Yutaka Oiso; Jiro Nakamura
Journal:  Diabetes       Date:  2008-08-26       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.